Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

Blood

Volumn 109, Issue 6, 2007, Pages 2322-2326

  Meisel, Roland ^a   Kuypers, Lisa ^a   Dirksen, Uta ^a   Schubert, Ralf ^b   Gruhn, Bernd ^c   Strauss, Gabriele ^d   Beutel, Karin ^e   Groll, Andreas H ^f   Duffner, Ulrich ^g   Blütters Sawatzki, Renate ^h   Holter, Wolfgang ⁱ   Feuchtinger, Tobias ^j   Grüttner, Hans Peter ^b   Schroten, Horst ^a   Zielen, Stefan ^b   Ohmann, Christian ^a   Laws, Hans Jürgen ^a   Dilloo, Dagmar ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY HOSPITAL GIESSEN   (Germany)

ⁱ UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^j UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNITY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 33947228517     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-06-032284     Document Type: Article

References (25)

1. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Bone Marrow Transplant. 1994;14:247-252.
2. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86:3979-3986.
3. Prager J, Baumert A, Gerike E, et al. Kinetic of the antibody titers to tetanus toxoid (TT), diphtheria toxoid (DT), measles virus, poliomyelitis virus and S. pneumoniae after marrow grafting. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116:533-540.
4. Ljungman P, Wiklund-Hammarsten M, Duraj V, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis. 1990;162:496-500.
5. Lum LG. Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am. 1990;4:659-675.
6. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant. 1991;7:89-93.
7. Prager J, Baumert A, Hermann J, Fuchs D, Zintl F. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: the kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation]. Kinderarztl Prax. 1992;60:124-130.
8. Parkkali T, Ruutu T, Stenvik M, et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS. 1996;104:383-388.
9. Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev. 1997;157:73-78.
10. Rege K, Mehta J, Treleaven J, et al. Fatal pneumococcal infections following allogeneic bone marrow transplant. Bone Marrow Transplant. 1994;14:903-906.
11. Schutze GE, Mason EO Jr, Wald ER, et al. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001;33:16-21.
12. Kulkarni S, Powles R, Treleaven J, et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood. 2000;95:3683-3686.
13. Engelhard D, Cordonnier C, Shaw PJ, et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol. 2002;117:444-450.
14. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1-125, CE121-127
15. Ljungman P, Engelhard D, de la Camara R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant. 2005;35:737-746.
16. Avanzini MA, Carra AM, Maccario R, et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol. 1995;15:137-144.
17. Spoulou V, Victoratos P, Ioannidis JP, Grafakos S. Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. J Infect Dis. 2000;182:965-969.
18. Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics. 1998;101:604-611.
19. Shinefield HR, Black S, Ray P, et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999;18:757-763.
20. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.
21. Zielen S, Broker M, Strnad N, et al. Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J Immunol Methods. 1996;193:1-7.
22. Zielen S, Buhring I, Strnad N, Reichenbach J, Hofmann D. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in non-responders to the 23-valent pneumococcal vaccine. Infect Immun. 2000;68:1435-1440.
23. Molrine DC, Antin JH, Guinan EC, et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood. 2003;101:831-836.
24. Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis. 2006;42:907-914.
25. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455-1463.